Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,555 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The Concise Guide to PHARMACOLOGY 2013/14: overview.
Alexander SP, Benson HE, Faccenda E, Pawson AJ, Sharman JL, McGrath JC, Catterall WA, Spedding M, Peters JA, Harmar AJ; CGTP Collaborators; Abul-Hasn N, Anderson CM, Anderson CM, Araiksinen MS, Arita M, Arthofer E, Barker EL, Barratt C, Barnes NM, Bathgate R, Beart PM, Belelli D, Bennett AJ, Birdsall NJ, Boison D, Bonner TI, Brailsford L, Bröer S, Brown P, Calo G, Carter WG, Catterall WA, Chan SL, Chao MV, Chiang N, Christopoulos A, Chun JJ, Cidlowski J, Clapham DE, Cockcroft S, Connor MA, Cox HM, Cuthbert A, Dautzenberg FM, Davenport AP, Dawson PA, Dent G, Dijksterhuis JP, Dollery CT, Dolphin AC, Donowitz M, Dubocovich ML, Eiden L, Eidne K, Evans BA, Fabbro D, Fahlke C, Farndale R, Fitzgerald GA, Fong TM, Fowler CJ, Fry JR, Funk CD, Futerman AH, Ganapathy V, Gaisnier B, Gershengorn MA, Goldin A, Goldman ID, Gundlach AL, Hagenbuch B, Hales TG, Hammond JR, Hamon M, Hancox JC, Hauger RL, Hay DL, Hobbs AJ, Hollenberg MD, Holliday ND, Hoyer D, Hynes NA, Inui KI, Ishii S, Jacobson KA, Jarvis GE, Jarvis MF, Jensen R, Jones CE, Jones RL, Kaibuchi K, Kanai Y, Kennedy C, Kerr ID, Khan AA, Klienz MJ, Kukkonen JP, Lapoint JY, Leurs R, Lingueglia E, Lippiat J, Lolait SJ, Lummis SC, Lynch JW, … See abstract for full author list ➔ Alexander SP, et al. Among authors: zimmermann m. Br J Pharmacol. 2013 Dec;170(8):1449-58. doi: 10.1111/bph.12444. Br J Pharmacol. 2013. PMID: 24528237 Free PMC article.
Viral clearance, pharmacokinetics and tolerability of ensovibep in patients with mild to moderate COVID-19: A phase 2a, open-label, single-dose escalation study.
Prins MLM, van der Plas JL, Vissers MFJM, Berends CL, Tresch G, Soergel M, Fernández E, van den Berge N, Duijsings D, Zitt C, Stavropoulou V, Zimmermann M, Drake RF, Burggraaf J, Groeneveld GH, Kamerling IMC. Prins MLM, et al. Among authors: zimmermann m. Br J Clin Pharmacol. 2023 Mar;89(3):1105-1114. doi: 10.1111/bcp.15560. Epub 2022 Oct 24. Br J Clin Pharmacol. 2023. PMID: 36214216 Free PMC article. Clinical Trial.
The International Bathymetric Chart of the Arctic Ocean Version 5.0.
Jakobsson M, Mohammad R, Karlsson M, Salas-Romero S, Vacek F, Heinze F, Bringensparr C, Castro CF, Johnson P, Kinney J, Cardigos S, Bogonko M, Accettella D, Amblas D, An L, Bohan A, Brandt A, Bünz S, Canals M, Casamor JL, Coakley B, Cornish N, Danielson S, Demarte M, Di Franco D, Dickson ML, Dorschel B, Dowdeswell JA, Dreutter S, Fremand AC, Hall JK, Hally B, Holland D, Hong JK, Ivaldi R, Knutz PC, Krawczyk DW, Kristofferson Y, Lastras G, Leck C, Lucchi RG, Masetti G, Morlighem M, Muchowski J, Nielsen T, Noormets R, Plaza-Faverola A, Prescott MM, Purser A, Rasmussen TL, Rebesco M, Rignot E, Rysgaard S, Silyakova A, Snoeijs-Leijonmalm P, Sørensen A, Straneo F, Sutherland DA, Tate AJ, Travaglini P, Trenholm N, van Wijk E, Wallace L, Willis JK, Wood M, Zimmermann M, Zinglersen KB, Mayer L. Jakobsson M, et al. Among authors: zimmermann m. Sci Data. 2024 Dec 21;11(1):1420. doi: 10.1038/s41597-024-04278-w. Sci Data. 2024. PMID: 39709502 Free PMC article.
Maintenance therapy with trofosfamide, idarubicin and etoposide in patients with rhabdomyosarcoma and other high-risk soft tissue sarcomas (CWS-2007-HR): a multicentre, open-label, randomised controlled phase 3 trial.
Koscielniak E, Ljungman G, Kazanowska B, Niggli F, Sparber-Sauer M, Handgretinger R, Zimmermann M, Boos J, Blank B, Hallmen E, Teichert von Lüttichau I, Schmid I, Fröhlich B, Müller HL, Behnisch W, Ladenstein R, Scheer M, Vokuhl C, von Kalle T, Blattmann C, Bielack S, Klingebiel T. Koscielniak E, et al. Among authors: zimmermann m. EClinicalMedicine. 2024 Nov 29;78:102957. doi: 10.1016/j.eclinm.2024.102957. eCollection 2024 Dec. EClinicalMedicine. 2024. PMID: 39687431 Free PMC article.
Sustained response to guselkumab regardless of baseline characteristics in patients with active psoriatic arthritis and inadequate response to TNF inhibitors: results from the phase 3b COSMOS clinical trial.
McInnes IB, Sewerin P, Sharaf M, Efficace M, Lavie F, Zimmermann M, Coates LC. McInnes IB, et al. Among authors: zimmermann m. RMD Open. 2024 Dec 12;10(4):e004494. doi: 10.1136/rmdopen-2024-004494. RMD Open. 2024. PMID: 39672591 Free PMC article. Clinical Trial.
2,555 results